Treatment of hepatitis C in hemodialysis patients using pegylated interferon alpha-2a in Turkey

Kose Ş., Gurkan A., Akman F., Kelesoglu M., Uner U.

JOURNAL OF GASTROENTEROLOGY, cilt.44, sa.4, ss.353-358, 2009 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 4
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s00535-009-0016-z
  • Dergi Adı: JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.353-358
  • Anahtar Kelimeler: Pegylated interferon alpha-2a, Hepatitis C infection, Hemodialysis patients, RENAL-DISEASE, VIRUS, MONOTHERAPY, INFECTION, RIBAVIRIN, KIDNEY
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Hepatitis C virus (HCV) is prevalent in renal insufficient patients. The aim of the present study was to evaluate the efficacy and tolerability of pegylated interferon alpha-2a (peg-IFN-alpha-2a) among these patients.